SPRY ARS Pharmaceuticals, Inc.
$3.69
ARS Pharmaceuticals, Inc. (SPRY) Earnings News
Earnings press releases, previews and reviews for ARS Pharmaceuticals, Inc. (SPRY), newest first. Our most recent is review: ARS Pharma Misses Badly on Revenue as Cost Reset Lands, but neffy Sales Still Trail Demand.
Thursday
November 5, 2026
5:49 PM ET
ARS Pharma Misses Badly on Revenue as Cost Reset Lands, but neffy Sales Still Trail Demand
Earnings Whispers · Review
Thursday
November 5, 2026
4:01 PM ET
ARS Pharma Reports Business Highlights and Third Quarter 2026 Financial Results
Wednesday
October 28, 2026
9:54 PM ET
ARS Pharmaceuticals Faces Proof Test as Cost Cuts Meet a Lofty Revenue Bar
Earnings Whispers · Preview
Wednesday
October 28, 2026
4:01 PM ET
ARS Pharma to Report Third Quarter 2026 Financial Results
Thursday
August 13, 2026
4:01 PM ET
ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results
Monday
August 3, 2026
7:30 AM ET
ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results
Wednesday
June 24, 2026
4:05 PM ET
ARS Pharmaceuticals Provides Commercial and Financial Updates